You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Oncgnostics, a Jena, Germany-based molecular diagnostic company, has out-licensed its GynTect cervical cancer test to Changchun Jienuo Medical Technology (CJMT), a subsidiary of Sinopharm Group in China.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.